Why the time is right to tackle breast and cervical cancer in low-resource settings;Pourquoi est-il temps de s'attaquer au cancer du sein et du col de l'utérus dans les milieux à faibles ressources?

Bulletin of the World Health Organization

Volumn 91, Issue 9, 2013, Pages 683-690

  Tsu, Vivien Davis ^a   Jeronimo, Jose ^a   Anderson, Benjamin O ^b  

^a PATH   (United States)

^b USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

CANCER; DEVELOPING WORLD; DISEASE TREATMENT; EPIDEMIOLOGY; HEALTH CARE; WOMENS HEALTH;

ALCOHOL CONSUMPTION; ARTICLE; BREAST CANCER; BREAST EXAMINATION; CANCER IMMUNIZATION; CANCER SCREENING; COMMUNITY PROGRAM; COST MINIMIZATION ANALYSIS; DRUG COST; FAT INTAKE; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE SYSTEM; HEALTH ECONOMICS; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; INCIDENCE; LIFESTYLE MODIFICATION; LOWEST INCOME GROUP; MAMMOGRAPHY; MORBIDITY; MORTALITY; PHYSICAL ACTIVITY; PRECANCER; UTERINE CERVIX CANCER; WART VIRUS; WOMEN'S HEALTH;

ADULT; BIOMEDICAL RESEARCH; BREAST NEOPLASMS; COST OF ILLNESS; DEVELOPING COUNTRIES; FEMALE; HEALTH RESOURCES; HUMANS; MIDDLE AGED; UTERINE CERVICAL NEOPLASMS;

EID: 84883318272     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.12.116020     Document Type: Article

References (47)

1. Rosenfield A, Maine D. Maternal mortality-a neglected tragedy. Where is the M in MCH? Lancet 1985;326:83-5. doi: http://dx.doi.org/10.1016/S0140-6736(85)90188-6 PMID:2861534
2. Hogan MC, Foreman KJ, Naghavi M, Ahn SY, Wang M, Makela SM et al. Maternal mortality for 181 countries, 1980-2008: a systematic analysis of progress towards Millennium Development Goal 5. Lancet 2010;375:1609-23. doi: http://dx.doi.org/10.1016/S0140-6736(10)60518-1 PMID:20382417
3. Trends in maternal mortality: 1990 to 2008. Geneva: World Health Organization, United Nations Children's Fund, United Nations Population Fund & The World Bank; 2010.
4. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM, editors. GLOBOCAN 2008 v1.2. Cancer incidence and mortality worldwide: IARC CancerBase No. 10. Lyon: International Agency for Research on Cancer; 2010. Available from: http://www.iarc.fr/en/publications/eresources/cancerbases/index.php [accessed 5 June 2013].
5. Matsuno RK, Costantino JP, Ziegler RG, Anderson GL, Li H, Pee D et al. Projecting individualized absolute invasive breast cancer risk in Asian and Pacific Islander American women. J Natl Cancer Inst 2011;103:951-61. doi: http://dx.doi.org/10.1093/jnci/djr154 PMID:21562243
6. Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, Murray CJL et al. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet 2011;378:1461-84. doi: http://dx.doi.org/10.1016/S0140-6736(11)61351-2 PMID:21924486
7. Whitehead M. The concepts and principles of equity and health. Copenhagen: World Health Organization, Regional Office for Europe; 1990 (EUR/ICP/RPD 414). Available from: salud. ciee. flacso. org. ar/flacso/optativas/equity_and_health. pdf [accessed 5 June 2013].
8. Knaul FM, Bhadelia A, Gralow J, Arreola-Ornelas H, Langer A, Frenk J. Meeting the emerging challenge of breast and cervical cancer in low-and middle-income countries. Int J Gynaecol Obstet 2012;119(Suppl 1):S85-8. doi: http://dx.doi.org/10.1016/j.ijgo.2012.03.024 PMID:22883910
9. Namasivayam A, Osuorah DC, Syed R, Antai D. The role of gender inequities in women's access to reproductive health care: a population-level study of Namibia, Kenya, Nepal, and India. Int J Womens Health 2012;4:351-64. PMID:22927766
10. Sen G, Östlin P. Unequal, unfair, ineffective and inefficient, gender inequity in health: why it exists and how we can change it. Stockholm: Karolinska Institute; 2007. Available from: http://www.who.int/social_determinants/resources/csdh_media/wgekn_final_report_07.pdf [accessed 5 June 2013].
11. Tsu VD, Levin CE. Making the case for cervical cancer prevention: what about equity? Reprod Health Matters 2008;16:104-12. doi: http://dx.doi.org/10.1016/S0968-8080(08)32411-2 PMID:19027628
12. Akinyemiju TF. Socio-economic and health access determinants of breast and cervical cancer screening in low-income countries: analysis of the World Health Survey. PLoS ONE 2012;7:e48834. doi: http://dx.doi.org/10.1371/journal.pone.0048834 PMID:23155413
13. Knaul FM, Frenk J, Shulman L. Closing the cancer divide: a blueprint to expand access in low and middle income countries. Boston: Harvard Global Equity Initiative; 2011. Available from: http://www.gavialliance.org/library/publications/searchtext/hgei/[accessed 5 June 2013].
14. Lu B, Kumar A, Castellsagué X, Giuliano AR. Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review & meta-analysis. BMC Infect Dis 2011;11:13. doi: http://dx.doi.org/10.1186/1471-2334-11-13 PMID:21226933
15. LaMontagne DS, Barge S, Le NT, Mugisha E, Penny ME, Gandhi S et al. Human papillomavirus vaccine delivery strategies that achieved high coverage in low-and middle-income countries. Bull World Health Organ 2011;89:821-830B. doi: http://dx.doi.org/10.2471/BLT.11.08986 PMID:22084528
16. Binagwaho A, Wagner CM, Gatera M, Karema C, Nutt CT, Ngabo F. Achieving high coverage in Rwanda's national human papillomavirus vaccination programme. Bull World Health Organ 2012;90:623-8. doi: http://dx.doi.org/10.2471/BLT.11.097253 PMID:22893746
17. Ladner J, Besson MH, Hampshire R, Tapert L, Chirenje M, Saba J. Assessment of eight HPV vaccination programs implemented in lowest income countries. BMC Public Health 2012;12:370. doi: http://dx.doi.org/10.1186/1471-2458-12-370 PMID:22621342
18. GAVI Alliance [Internet]. Human papillomavirus vaccine support. Geneva: GAVI; 2012. Available from: http://www.gavialliance.org/support/nvs/human-papillomavirus-vaccine-support/[accessed 5 June 2013].
19. Tabrizi SN, Brotherton JM, Kaldor JM, Skinner SR, Cummins E, Liu B et al. Fall in human papillomavirus prevalence following a national vaccination program. J Infect Dis 2012;206:1645-51. doi: http://dx.doi.org/10.1093/infdis/jis590 PMID:23087430
20. Kahn JA, Brown DR, Ding L, Widdice LE, Shew ML, Glynn S et al. Vaccine-type human papillomavirus and evidence of herd protection after vaccine introduction. Pediatrics 2012;130:e249-56. doi: http://dx.doi.org/10.1542/peds.2011-3587 PMID:22778297
21. Brotherton JM, Fridman M, May CL, Chappell G, Saville AM, Gertig DM. Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. Lancet 2011;377:2085-92. doi: http://dx.doi.org/10.1016/S0140-6736(11)60551-5 PMID:21684381
22. Franceschi S, Denny L, Irwin KL, Jeronimo J, Lopalco PL, Monsonego J et al. Eurogin 2010 roadmap on cervical cancer prevention. Int J Cancer 2011;128:2765-74. doi: http://dx.doi.org/10.1002/ijc.25915 PMID:21207409
23. Sankaranarayanan R, Nessa A, Esmy PO, Dangou JM. Visual inspection methods for cervical cancer prevention. Best Pract Res Clin Obstet Gynaecol 2012;26:221-32. doi: http://dx.doi.org/10.1016/j.bpobgyn.2011.08.003 PMID:22075441
24. Cervical Cancer Action [Internet]. Progress in cervical cancer prevention: the CCA report card. Atlanta: CCA; 2012. http://www.cervicalcanceraction.org/pubs/pubs.php [accessed 5 June 2013].
25. Sankaranarayanan R, Rajkumar R, Esmy PO, Fayette JM, Shanthakumary S, Frappart L et al. Effectiveness, safety and acceptability of 'see and treat' with cryotherapy by nurses in a cervical screening study in India. Br J Cancer 2007;96:738-43. doi: http://dx.doi.org/10.1038/sj.bjc.6603633 PMID:17311015
26. Sankaranarayanan R, Esmy PO, Rajkumar R, Muwonge R, Swaminathan R, Shanthakumari S et al. Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. Lancet 2007;370:398-406. doi: http://dx.doi.org/10.1016/S0140-6736(07)61195-7 PMID:17679017
27. Sankaranarayanan R, Nene BM, Shastri SS, Jayant K, Muwonge R, Budukh AM et al. HPV screening for cervical cancer in rural India. N Engl J Med 2009;360:1385-94. doi: http://dx.doi.org/10.1056/NEJMoa0808516 PMID:19339719
28. Jeronimo J. 165 new screening algorithms for population-based programs. Int J Gynecol Obstet 2012;119:S202.
29. McTiernan A, Porter P, Potter JD. Breast cancer prevention in countries with diverse resources. Cancer 2008;113(Suppl):2325-30. doi: http://dx.doi.org/10.1002/cncr.23829 PMID:18837024
30. Beral V, Alexander M, Duffy S, Ellis IO, Given-Wilson R, Holmberg L et al. The number of women who would need to be screened regularly by mammography to prevent one death from breast cancer. J Med Screen 2011;18:210-2. doi: http://dx.doi.org/10.1258/jms.2011.011134 PMID:22184734
31. Mittra I. Breast cancer screening in developing countries. Prev Med 2011;53:121-2. doi: http://dx.doi.org/10.1016/j.ypmed.2011.06.010 PMID:21712052
32. Mittra I, Mishra GA, Singh S, Aranke S, Notani P, Badwe R et al. A cluster randomized, controlled trial of breast and cervix cancer screening in Mumbai, India: methodology and interim results after three rounds of screening. Int J Cancer 2010;126:976-84. PMID:19697326
33. Sankaranarayanan R, Ramadas K, Thara S, Muwonge R, Prabhakar J, Augustine P et al. Clinical breast examination: preliminary results from a cluster randomized controlled trial in India. J Natl Cancer Inst 2011;103:1476-80. doi: http://dx.doi.org/10.1093/jnci/djr304 PMID:21862730
34. US Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009;151:716-26, W-236. doi: http://dx.doi.org/10.7326/0003-4819-151-10-200911170-00008 PMID:19920272
35. Bevers TB, Anderson BO, Bonaccio E, Buys S, Daly MB, Dempsey PJ et al.; National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis. J Natl Compr Canc Netw 2009;7:1060-96. PMID:19930975
36. Tsu VD, Winkler JL, Anderson BO, Sarria G, Jeronimo J. Coordinated training on early detection and diagnosis of breast cancer across different levels of health workers: an example from Peru. In: Shetty MK, editor. Breast and gynecological cancers: an integrated approach for screening and early diagnosis in developing countries. New York: Springer; 2013. Available from: http://link.springer.com/content/pdf/10.1007%2F978-1-4614-1876-4_14.pdf# [accessed 5 June 2013].
37. Knaul FM, Nigenda G, Lozano R, Arreola-Ornelas H, Langer A, Frenk J. Breast cancer in Mexico: a pressing priority. Reprod Health Matters 2008;16:113-23. doi: http://dx.doi.org/10.1016/S0968-8080(08)32414-8 PMID:19027629
38. Caleffi M, Ribeiro RA, Bedin AJ Jr, Viegas-Butzke JM, Baldisserotto FD, Skonieski GP et al. Adherence to a breast cancer screening program and its predictors in underserved women in southern Brazil. Cancer Epidemiol Biomarkers Prev 2010;19:2673-9. doi: http://dx.doi.org/10.1158/1055-9965.EPI-10-0338 PMID:20716620
39. Anderson BO, Yip CH, Smith RA, Shyyan R, Sener SF, Eniu A et al. Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the Breast Health Global Initiative Global Summit 2007. Cancer 2008;113(Suppl):2221-43. doi: http://dx.doi.org/10.1002/cncr.23844 PMID:18816619
40. Eniu A, Carlson RW, El Saghir NS, Bines J, Bese NS, Vorobiof D et al.; Breast Health Global Initiative Treatment Panel. Guideline implementation for breast healthcare in low-and middle-income countries: treatment resource allocation. Cancer 2008;113(Suppl):2269-81. doi: http://dx.doi.org/10.1002/cncr.23843 PMID:18837019
41. Programme of Action for Cancer Therapy. Progress report: autumn/winter 2011. Vienna: International Atomic Energy Agency; 2011. Available from: cancer. iaea. org/documents/PACTProgressReport2011_2. pdf [accessed 5 June 2013].
42. Stalsberg H, Awuah B, Ibarra JA, Nsiah-Asare A. Re-establishing a surgical pathology service in Kumasi, Ghana: case report and discussion of barriers and key elements of a successful collaboration between low-and high-resource countries. Cancer 2008;113(Suppl):2338-46. doi: http://dx.doi.org/10.1002/cncr.23830 PMID:18837026
43. Sohani AR, Sohani MA. Static digital telepathology: a model for diagnostic and educational support to pathologists in the developing world. Anal Cell Pathol (Amst) 2012;35:25-30. PMID:22233701
44. Masood S, Vass L, Ibarra JA Jr, Ljung B-M, Stalsberg H, Eniu A et al.; Breast Health Global Initiative Pathology Focus Group. Breast pathology guideline implementation in low-and middle-income countries. Cancer 2008;113(Suppl):2297-304. doi: http://dx.doi.org/10.1002/cncr.23833 PMID:18837021
45. Comprehensive cervical cancer prevention and control: a healthier future for girls and women. Geneva: World Health Organization; 2013.
46. Political declaration of the High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases. In: General Assembly of the United Nations [Internet]. Sixty-sixth session of the General Assembly of the United Nations, New York, 19-20 September 2012. New York: United Nations; 2012 (A/RES/66/2).
47. A draft comprehensive global monitoring framework, including indicators, and a set of voluntary global targets for the prevention and control of noncommunicable diseases. Geneva: World Health Organization; 2012 (A/NCD/INF./1). Available from: http://apps.who.int/gb/ncds/pdf/A_NCD_INF1-en.pdf [accessed 5 June 2013].